Dec. 17, 2002 — In patients with hypercholesterolemia and hypertension, pravastatin was no better than usual care in reducing deaths or coronary heart disease (CHD) events, according to results of the ...

Boca Raton, FL - A new meta-analysis of major pravastatin secondary-prevention trials has shown that the benefits from aspirin and statins are additive and may even be synergistic. The authors of the ...

Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT). P In the PROVE IT trial, 5 4162 patients who had been hospitalized for an acute coronary syndrome (ACS) within the previous 10 ...

Older patients without existing atherosclerotic cardiovascular disease do not receive any benefit from statin therapy, according to a new analysis of the lipid-lowering arm of the ALLHAT trial. After ...

Please provide your email address to receive an email when new articles are posted on . Pravastatin compared with placebo did not reduce incidence of delivery with preeclampsia among pregnant women at ...

NEW ORLEANS–Several recent cardiovascular (CV) clinical trials have shown the benefit of aggressive lipid-lowering therapy. They have also highlighted the inadequacy of statin monotherapy in clinical ...

Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non–Small-Cell Lung Cancer: AF-001JP Patients with confirmed SCLC (limited or extensive disease) and performance status 0 to 3 ...

Prevastatin is prescribed for conditions including high cholesterol in adults and some children. It’s a generic medication that isn’t available as a brand-name drug. The drug comes as an oral tablet.

Patients with confirmed SCLC (limited or extensive disease) and performance status 0 to 3 were randomly assigned to receive daily pravastatin 40 mg or placebo, combined with up to six cycles of ...